Clinical trial
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
NCT00064753 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00064753 |
|---|---|
| Title | Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) |
| Official title | Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) |
| Acronym | FAVORIT |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Office of Dietary Supplements (ODS) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Cardiovascular Disease, Death |
| Intervention type | Device, Drug |
| Interventions | High Dose Multivitamin, Low Dose Multivitamin |
| Enrollment | 4,110 |
| Start date | May 1, 2002 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Jul 15, 2003 |
| Last update posted | Oct 18, 2017 |
| Countries | Brazil, Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: